Trial Details

RECRUITING
Basic Information
Clinical ID c270
Identifier NCT06865417
Trial Title A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Filgotinib
Participant Information
Sponsor Alfasigma S.p.A.
City Brussels Capital
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-09-29
Primary Completion Date 2028-06
Completion Date 2028-06